Prescription Alternatives to Over-the-Counter Medications for Seasonal Allergies
For a healthy adult seeking alternatives to over-the-counter medications for seasonal allergic rhinitis, prescribe an intranasal corticosteroid (such as fluticasone, mometasone, or budesonide) as first-line therapy, and consider allergen immunotherapy (subcutaneous or sublingual) as the only disease-modifying non-pharmacologic option. 1
Prescription Pharmacologic Options
First-Line: Intranasal Corticosteroids
The 2017 Joint Task Force guidelines provide a strong recommendation for intranasal corticosteroids as monotherapy for initial treatment of seasonal allergic rhinitis in adults. 1 These are superior to:
- Oral antihistamines (even when combined with intranasal corticosteroids - adding oral antihistamines provides no additional benefit) 1
- Leukotriene receptor antagonists (montelukast) - intranasal corticosteroids demonstrate significantly better efficacy 1
Common prescription intranasal corticosteroids include:
- Fluticasone propionate
- Mometasone furoate
- Budesonide
- Triamcinolone
For Moderate-to-Severe Disease
If symptoms remain inadequately controlled with intranasal corticosteroids alone, add an intranasal antihistamine (such as azelastine or olopatadine) to the intranasal corticosteroid. 1 This combination provides clinically meaningful symptom reduction beyond monotherapy, with studies showing 40% greater relative improvement compared to either agent alone. 1
Important caveat: This is a weak recommendation due to potential adverse effects including dysgeusia (altered taste, occurring in 2-13% of patients) and mild somnolence (0.4-1.1%). 1 The combination is most appropriate when monotherapy fails to control symptoms adequately.
What NOT to Prescribe
Do not routinely combine intranasal corticosteroids with oral antihistamines - this provides no clinically meaningful benefit over intranasal corticosteroid monotherapy alone. 1 This is a strong recommendation based on moderate-quality evidence.
Non-Pharmacologic Disease-Modifying Treatment
Allergen Immunotherapy
Allergen immunotherapy (either subcutaneous or sublingual) is the only disease-modifying therapeutic option for seasonal allergic rhinitis. 1 This represents a true alternative approach rather than symptom management.
Consider immunotherapy for patients with:
- Moderate-to-severe seasonal allergic rhinitis
- Inadequate response to pharmacotherapy
- Desire for long-term disease modification rather than ongoing medication use
- Willingness to commit to 3-5 years of treatment
This approach actually alters the underlying immune response rather than simply suppressing symptoms, making it the most definitive non-pharmacologic intervention available.
Practical Algorithm
Step 1: Start with prescription intranasal corticosteroid monotherapy
Step 2: If inadequate control after 2-4 weeks, add intranasal antihistamine to the intranasal corticosteroid
Step 3: For patients seeking disease modification or long-term solution, refer for allergen immunotherapy evaluation
What to avoid: Allergen avoidance strategies are generally inadequate for outdoor allergens that cause seasonal allergic rhinitis, unlike indoor allergen management. 1
Key Clinical Pitfalls
- Don't prescribe leukotriene receptor antagonists as first-line therapy - they are significantly less effective than intranasal corticosteroids 1
- Don't add oral antihistamines to intranasal corticosteroids - this common practice lacks evidence of benefit 1
- Don't overlook immunotherapy - many clinicians focus only on symptom suppression when disease modification is available 1